Locations:
Search IconSearch

Cancer

cells with idiopathic multicentric Castleman Disease
February 20, 2025/Cancer/News & Insight

Study Offers New Insights into Idiopathic Multicentric Castleman Disease

Highlighting treatment gaps and challenges in the management of rare condition

CAR T-cell therapy
February 18, 2025/Cancer/News & Insight

Top Myths About CAR T-Cell Therapy for Multiple Myeloma

Explaining common misconceptions about chimeric antigen receptor therapy

X-ray of pelvis implant
February 17, 2025/Orthopaedics/Tumor

3D-Printed Pelvis Implant Restores Function After Sarcoma Resection

Personalized reconstruction is an alternative to leg amputation or flail limb

Silhouettes of man and woman
February 7, 2025/Cancer/News & Insight

Pharmacokinetics of Many Anticancer Drugs Differ Among Sexes

Slower drug elimination from the body among females may impact safety and efficacy

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

Mobile mammography van
February 6, 2025/Cancer/News & Insight

Increasing Breast Cancer Screening in Women Experiencing Homelessness

Partnerships with local social service agencies key to program success

Eye melanoma
February 4, 2025/Cancer

Novel Neoadjuvant Treatment Trial for Uveal Melanoma

Oral medication may have potential to preserve vision and shrink tumors prior to surgery or radiation

Specialty pharmacy
January 24, 2025/Cancer/News & Insight

Researchers Seek Actionable Ways to Reduce Time to Treatment of Multiple Myeloma

Study examines modifiable determinants of health disparities

Woman wearing pink scarf
January 17, 2025/Cancer/News & Insight

Exceptional Responders to Metastatic Breast Cancer Treatment Characterized

Findings may guide future research and personalized treatments

Dr. Rotz sits with a patient

Managing Cardiac Issues in Patients Undergoing Bone Marrow Transplantation

AHA recommendations for pretransplant evaluation, peritransplant and long-term management

Tumor-Infiltrating Lymphocytes (TIL) therapy
January 6, 2025/Cancer/News & Insight

Tumor-Infiltrating Lymphocytes Therapy Now Available for Treating Unresectable or Metastatic Melanoma

Cleveland Clinic Cancer Institute among select group of centers to administer highly personalized treatment

BackPage 1 of 116Next

Advertisement

Ad